Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Net Margin (2020 - 2022)

Historic Net Margin for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to 2960184.4%.

  • Immuneering's Net Margin fell 29543967400.0% to 2960184.4% in Q4 2022 from the same period last year, while for Sep 2023 it was 11588326.59%, marking a year-over-year decrease of 115787957500.0%. This contributed to the annual value of 15937.29% for FY2022, which is 143249700.0% down from last year.
  • As of Q4 2022, Immuneering's Net Margin stood at 2960184.4%, which was down 29543967400.0% from 33781.04% recorded in Q3 2022.
  • Immuneering's 5-year Net Margin high stood at 644.49% for Q3 2020, and its period low was 2960184.4% during Q4 2022.
  • For the 3-year period, Immuneering's Net Margin averaged around 274998.48%, with its median value being 1768.4% (2021).
  • Per our database at Business Quant, Immuneering's Net Margin crashed by -4606200bps in 2021 and then plummeted by 2000000000bps in 2022.
  • Over the past 3 years, Immuneering's Net Margin (Quarter) stood at 877.48% in 2020, then plummeted by -560bps to 5787.65% in 2021, then crashed by -51047bps to 2960184.4% in 2022.
  • Its Net Margin was 2960184.4% in Q4 2022, compared to 33781.04% in Q3 2022 and 12183.19% in Q2 2022.